Case Study: U.S. Food and Drug Administration achieves 99%+ accurate, rapid adverse-event data capture with ABBYY’s Digital Intelligence Platform

ABBYY’s Digital Intelligence Platform transforms the U.S. Food and Drug Administration

The U.S. Food and Drug Administration, tasked with protecting public health, needed a scalable way to ingest and make sense of hundreds of thousands of electronic health files and a thirty-year backlog of more than two dozen form versions—some with up to 120 complex fields—where speed and accuracy are critical to capturing adverse-event reports.

ABBYY’s Digital Intelligence platform digitized and extracted data from electronic, paper and PDF documents at scale, processing thousands of pages per day and feeding high-quality data into downstream workflows and visualization tools. The solution delivered 99%+ accuracy, modernized FDA reporting processes, and ensured adverse events are recorded and routed quickly and reliably.

Food and Drug Administration

Justin Scott

Deputy to the Deputy Director